Endocrine Abstracts

IntroductionMulticentric Castleman disease (MCD) is characterized by highly vascularized multiple lymph node enlargements throughout the body. MCD is generally treated with systemic cytotoxic chemotherapy, with its attendant risk for toxicity. Studies suggest the presence of growth hormone receptors (GHR) in lymphatic tissues of patients with Castleman disease. However, the effect of somatostatin analogs for the treatment of MCD is not reported so far. H...